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Abstract
Finding sequences that control expression of genes is central to understanding genome function. Previous studies have
used evolutionary conservation as an indicator of regulatory potential. Here, we present a method for the unbiased in vivo
screen of putative enhancers in large DNA regions, using the mouse as a model. We cloned a library of 142 overlapping
fragments from a 200 kb-long murine BAC in a lentiviral vector expressing LacZ from a minimal promoter, and used the
resulting vectors to infect fertilized murine oocytes. LacZ staining of E11 embryos obtained by first using the vectors in
pools and then testing individual candidates led to the identification of 3 enhancers, only one of which shows significant
evolutionary conservation. In situ hybridization and 3C/4C experiments suggest that this enhancer, which is active in the
neural tube and posterior diencephalon, influences the expression of the Olig1 and/or Olig2 genes. This work provides a new
approach for the large-scale in vivo screening of transcriptional regulatory sequences, and further demonstrates that
evolutionary conservation alone seems too limiting a criterion for the identification of enhancers.
Citation: Friedli M, Barde I, Arcangeli M, Verp S, Quazzola A, et al. (2010) A Systematic Enhancer Screen Using Lentivector Transgenesis Identifies Conserved and
Non-Conserved Functional Elements at the Olig1 and Olig2 Locus. PLoS ONE 5(12): e15741. doi:10.1371/journal.pone.0015741
Editor: Roland G. Roberts, King’s College London, United Kingdom
Received August 22, 2010; Accepted November 23, 2010; Published December 29, 2010
Copyright:  2010 Friedli et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: MF is supported by a fellowship from the National Centre For Competence in Research (NCCR) ‘‘Frontiers in Genetics’’ doctoral school. This work was
supported by grants from the NCCR ‘‘Frontiers in Genetics’’ (to DD, DT, SEA), the Swiss National Science Foundation (to DD, DT, SEA), the Childcare Foundation (to
SEA), and the European programs ‘‘Crescendo’’ (to DD), ‘‘CONSERT’’ (to DT) and ‘‘AnEUploidy’’ (to SEA). The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: didier.trono@epfl.ch (DT); stylianos.antonarakis@unige.ch (SEA); denis.duboule@unige.ch (DD)
¤a Current address: Genomics Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America
¤b Current address: Developmental Biology Program, European Molecular Biology Laboratory, Heidelberg, Germany
Introduction
The identification of sequences that control spatial, temporal
and quantitative expression of genes is important to understand
genome function. Other than the core promoter, several other cis-
acting regulatory elements are required for accurate gene
expression (reviewed in [1]). For instance, enhancers, by mediating
expression within a specific tissue or cell type, are responsible for a
subset of the total gene expression pattern. Insulators on the other
hand, act as boundary elements and prevent cis-regulatory
sequences in one gene from inappropriately interacting with
adjacent loci [2]. These elements may reside in introns or up- and
downstream of the transcription unit. Cis-regulatory domains can
extend long distances outside the transcription unit; an enhancer
for Sonic Hedghog for example is located one megabase away
from its target gene [3]. The importance of these cis-acting
elements has been underscored by several examples of nucleotide
variation in enhancers that elicit human disorders [3,4,5,6,7].
The recent sequencing of genomes has added a pivotal tool for
genome analysis in the form of comparisons and multiple align-
ments. These comparative genomics approaches have provided
cues in the discovery of both protein-coding genes as well as
potentially functional conserved non-coding elements (CNCs)
[8,9,10,11,12,13,14]. The conclusion of these studies is that
functionally relevant sequences are conserved through evolution,
while the remainder of the genome evolves neutrally. Given the
early availability of both the human and mouse genomes, initial
efforts focused on human–mouse pair-wise comparisons; but
subsequent studies frequently used more distant comparisons such
as human-fish to uncover functional non-coding elements with a
higher stringency [15][16].
We previously tested the potential enhancer activity of a set of
CNCs through a reporter-based assay in human cell lines, and
found that only a small fraction of them scored positively [17].
However, studies using transgenic mice and more stringent
evolutionary criteria demonstrated that a substantial subset of
conserved non-coding sequences have transcriptional enhancer
activity [13,18,19]. We thus developed a systematic approach to
screen in vivo for putative enhancers in large genomic regions.
Because evolutionary conservation may overlook functional
elements, we further designed our method avoiding any bias
towards particular sequence features. For this, we cloned a library
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of fragments from a mouse genomic sequence in a lentiviral vector,
next to a minimal promoter-reporter cassette. We then tested the
reporter gene expression by lentivector-mediated mouse transgen-
esis, which allowed us to generate and analyze rapidly a high
number of embryos. This screen identified three enhancers in a
200 kb-long orthologous region from human chromosome 21.
Interestingly, only one of these three elements, which likely
controls the nearby Olig genes, is evolutionarily conserved.
Results
Generation of a lentivector-based library of candidate
enhancers
Previous studies have used evolutionary conservation as an
indicator of regulatory potential, but increasing evidence suggests
that this criterion alone frequently overlooks functional sequences
[20]. We thus designed our study without any bias towards a
particular sequence feature. We chose a mouse BAC (RP23-
356P18, chr16: 90990720-91210330,Mm8) corresponding to a
region of Hsa21 because it contains the Olig1 and Olig2 genes that
are expressed specifically in the CNS [21,22] (http://www.
eurexpress.org/ee/). In addition, this fragment overlaps with an
orthologous region studied in the ENCODE project pilot phase
(ENm005) [23], providing additional data on the locus. In order to
screen this fragment systematically for enhancer activity, we
generated a library (Figure 1b) of 142 overlapping clones (sizes:
1.5–4 kb) in a LacZ reporter lentiviral vector (LV) construct
containing a minimal promoter (pRRLbLac, Figure 1a). Lenti-
vectors are suitable for this kind of application due to their
relatively large cloning capacity of around 10 kb between the
LTRs without much of a drop in titer. The library was generated
by partial digestion of the BAC with CvIJ and gaps were filled-in
by cloning of PCR fragments. After exclusion of a 5.5 kb gap
composed mostly of an LTR (chr16: 91,140,442-91,145,979
Mm8), the coverage of the library is .90%, with an average
clone length of 2352 bp.
In vivo screening by lentivector-mediated transgenesis
Lentiviral vectors can efficiently integrate into the genomes of
early blastomeres following infection of zygotes from a wide
variety of species including mice, rats, pigs, cows, and chickens
[24,25]. After injection of concentrated LV under the zona
pellucida of a mouse fertilized oocyte, integration occurs at the 2-
to 4-cell stage, resulting in usually one to a few but in some cases
up to 15–20 proviral copies per transgenic animal [26]. From a
routine injection session, fifty transgenic embryos with a given
vector could be obtained. We thus decided to inject our library of
lentiviral vectors in pools rather than individually, and to trace
them back by PCR amplification of embryonic DNA, using
primers specific for the library fragments contained in the
proviruses. Vectors were produced separately by transient
transfection of 293T cells and pooled during the concentration
step. This appeared more suitable than the transfection of pooled
plasmids, where competition between LV genomic RNAs for
packaging during production, which could occur if some members
of the library bore detrimental elements such as introns, cryptic
polyA signals or RNA secondary structures, might introduce a
bias. In parallel, each LV was titrated individually. As expected,
vectors with larger inserts yielded lower titers, which in turn
correlated with their less frequent representation in the transgenic
embryos. LV titer is indeed a critical parameter, as in our hands
vectors with a titer below 16108 TU/ml hardly yield any
transgenic animals. After pooling, the infectious titers of individual
vectors was in the range 16108 TU/ml, which predicted that each
would be present in only a fraction of the embryos injected with
the pool.
As a proof of principle, we first injected oocytes with a vector
containing the well-characterized Sonic hedghehog limb enhancer
[3], and performed LacZ staining on E11 embryos. All resulting
transgenic embryos exhibited the expected limb bud domain
staining (n = 30) (Figure 1c). Some embryos also showed some
expression in other domains, but variable from one embryo to the
other. This kind of variable random activity is also seen in embryos
injected with an enhancer-less pRRLbLac, suggesting that it is due
to some ‘‘enhancer trapping’’ effect (i.e. activation of the reporter
by an endogenous enhancer located in the neighborhood of the
transgene integration site, later referred to as ‘‘position effect’’). It
is more frequently seen when stocks with high MOI are used, and
we therefore worked in conditions to minimize this. For example,
under these conditions, the injection of the enhancer-less reporter
yielded three LacZ positive embryos out of twenty transgenic ones
(15%), two of which showed a broad and diffuse pattern, the third
having staining in specific structures (Figure 1c). We attribute these
cases to position effects, which do not impede on accurate
identification of genuine signals coming from tissue-specific
enhancers, since the ectopic signals associated with this "back-
ground" activity occurred stochastically, usually in restricted
regions of the embryos and were not seen reproducibly in several
embryos. We then proceeded with the LV library. In total, 8 pools
of 10 or 20 vectors were injected (pools A to H, Table S2)
representing a total of 109 clones (95 after exclusion of redundant
clones, Table S3) and covering 173 kb, with no overlap. 81 (85%
of injected) clones yielded integrants representing 162.7 kb (74%
of the BAC). LacZ expression patterns were noted, and matched
with the genotype of each embryo. Table 1 shows the results
obtained with pool B as an example. The eight pools tested yielded
84 of 370 LacZ positive embryos with,2.3 transgenes per embryo
(Table 2). Real time quantitative PCR data from pool A revealed
that while most vectors were present in more than one embryos,
each usually integrated as a single copy in a given embryo (data
not shown). This effort allowed us to try and correlate LacZ
expression patterns with the presence of particular LV clones.
Candidate vectors thereby identified as potentially containing an
enhancer were then re-injected individually to confirm activity.
Identification of non-conserved and conserved
enhancers
In pool B, 3 embryos (185,189,190) were found to have staining
in the trigeminal ganglion, all of which had integrated LV clone
5A5 (Mm8 Chr16: 91096078-91097808), pointing to the corre-
sponding DNA insert as a good enhancer candidate. When this
clone was re-injected individually, 4/6 (66%) embryos exhibited
staining in the trigeminal ganglion (Figure 2). This proportion was
significantly (p = 4.961024) above the background staining of this
Figure 1. Generation of a lentiviral vector library. (A) Lentiviral vector in which each fragment of the library was cloned. SIN = self inactivating
LTR, BG=beta globin promoter, LacZ= LacZ reporter. (B) UCSC genome browser view (http://genome.ucsc.edu/ [27]) of the locus screened. Orange
boxes represent each clone of the library. The injected pools are shown below as coloured boxes. The corresponding segment in the human genome
is included in the pilot ENCODE region ENm005 [23]. (C) Left: Embryos injected with pRRLbLac (empty vector), showing no staining, broad and
unspecific b galactosidase pattern, or specific but not reproducible patterns. Right: Embryo injected with the Shh limb enhancer (positive control).
doi:10.1371/journal.pone.0015741.g001
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Table 1. Genotyping Table.
Clone
Embryo
number 5A5 5C7 5D6 5G1 5H8 5I7 6E6 6F7 7D7 5I2
Nb of different clones
integrated
59 x x x x x 5
60 x x 2
61 x x x x x x x 7
62 x x 2
63 x 1
64 x 1
65 0
66 x x x 3
67 0
68 x x x x x x 6
69 x 1
70 x x 2
71 x x 2
72 x x x x 4
91 x x x 3
92 x x x 3
93 x x x x x x x 7
94 x x x x 4
177 x x x x 4
178 x x 2
179 x x 2
180 x x x x x x x 7
181 x x x 3
182 0
183 x x 2
184 x x 2
185 x x x 3
186 x x x x x 5
187 x x x x x x x 7
188 0
189 x 1
190 x x x x x x 6
191 x x x x 4
192 x x 2
193 x x x x x x 6
194 x x 2
195 0
196 x x x 3
197 x x x x 4
198 x x x x x 5
199 x x 2
200 x x x x 4
201 x x x 3
20 20 12 10 21 0 0 21 25 0
Example of a genotyping table. Pool B clones are displayed horizontally and embryo numbers vertically. X indicates that the embryo integrated the corresponding
clone. Embryo numbers in bold face indicate LacZ positive animals. Candidate clones were identified by first looking for a repetition of a specific staining pattern among
embryos injected with a pool of sequences. Within the subset of embryos that displayed the same pattern, we looked for common integrated clones. These fragments
were the candidate enhancers to be injected individually for confirmation.
doi:10.1371/journal.pone.0015741.t001
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anatomical region in the totality of the transgenic embryos (6.6%).
Noteworthy, the BAC fragment contained in this clone is not
evolutionarily conserved based on current annotations and detec-
tion methods (UCSC genome browser [27], Vertebrate Multiz
Alignment & PhastCons Conservation [28],). Another clone (5B3,
from pool F, Mm8 Chr16: 91155139–91157882), containing an
insert located 57 kb downstream of 5A5, similarly induced
expression in the trigeminal ganglion (Figure 2), although in this
case the penetrance of the phenotype was lower (41%, n= 22),
albeit highly significant (p = 861024). This enhancer was also not
evolutionarily conserved (Figure 2).
In contrast, the third transcriptional enhancer identified carried
by clone 5F7 (Mm8 Chr16: 91097068–91100177), from a
genomic fragment located 17.3 kb upstream of Olig2, is highly
conserved (Figure 3a). The corresponding vector induced
consistent staining in the neural tube (71% embryos, n = 7,
p = 8*1025) and brain (57%, n= 7) (Figure 3b). While 5F7
contains a 1.5 kb block of strong evolutionary conservation
(Figure 3a), this region was found to yield only small peaks of
DNase I hypersensitivity in human cell lines (ENCODE data;
[23]). The specificity of this enhancer is particularly interesting
since it could participate in controlling the expression pattern of
the Olig genes. However, when transduced in cell lines, 5F7
induced LacZ expression in all cells tested whether they expressed
Olig genes (U87, HL60) or not (K562, 293T, HCT116) (not
shown).
When oocytes were injected with a minimal promoter LacZ
vector containing only the conserved segment of clone 5F7 (5F7
CNC, Figure 3a), the resulting embryos again showed neural tube
staining (54% embryos, n = 24, p = 1*1024, Figure 3c). This 1.5 kb
genomic is thus sufficient to confer the phenotype. Interestingly, it
was predicted to be functional in a recent in silico study based on
sequence conservation and density of potential transcription factor
binding sites [29].
Orthologous 5F7 sequences demonstrate CNS enhancer
activity
We further characterised this enhancer by testing the activity of
orthologous human (hg18: chr21:3393019930-3393049097, 2168 bp)
and chicken sequences (710 bp, galGal3: chr1:108,639,445–108,
640,154). Orthologous coordinates of human and chicken sequences
were obtained through the UCSC genome browser and the segments
were PCR amplified using primers within the intervals (Vista
alignment is shown in Figure 3a). We find that both human and
chicken 5F7 elements display strong enhancer activity in the CNS.
The most penetrant phenotype was staining in the posterior
diencephalon with 94% (p,10210, n=17) and 81% (p,10210,
n=16) of embryos showing this pattern with the chicken (Figure 3d)
and human (Figure 3e) elements, respectively. Expression of the
reporter was also present in the neural tube as with the mouse
element, although with a lower frequency (52% for the chicken
element, n=17, p=6.9*1026; 31% for the human, n=16,
p=7.7*1023). Collectively, these data identify clone 5F7 as a strong
CNS enhancer with reproducible staining in the posterior dienceph-
alon and neural tube. Both phenotypes were seen for human, mouse
and chicken orthologs, but the penetrance varied depending on the
species of origin (Table 3). Human and chicken elements were almost
identical, while the mouse ortholog drove expression of the reporter
more frequently in the neural tube and less frequently in the posterior
diencephalon. This could reflect a different interpretation of a
functional element due to species-specific transcription factors.
Alternatively, it is possible that parts of the functional module are
missing for some of our constructs, since we do not know the exact
boundaries of the activity. For example, the mouse element could
span a larger genomic fragment than its human and chicken
counterparts; and our construct could thus lack part of the required
sequences.
Olig gene expression overlaps with 5F7-LacZ stainings
Since the activity of clone 5F7 is specific to the CNS, in the
neural tube and posterior diencephalon, we hypothesized that it
could be responsible for part of the expression pattern of the
nearby Olig genes. Olig1 and Olig2 (oligodendrocyte transcription
factor) are bHLH transcription factors [22] that promote
formation and maturation of oligodendrocytes. They cooperate
to establish the progenitors of motor neurons (pMNs) in the
embryonic neural tube. Since Olig1 and Olig2 are clustered and act
in concert to differentiate oligodendrocytes, it is possible they
belong to the same regulatory landscape [30,31] and are co-
regulated by shared cis-elements. To test whether the expression of
Olig genes overlapped with our LacZ stainings of clone 5F7, we
performed in situ hybridization at E11.5 on histological sections
(Figure 4). We then compared these ISH patterns with virtual
sections of 5F7 LacZ stainings generated by optical projection
Table 2. Pools of lentivectors injected.
Pool Number of vectors LacZ positive embryos Total embryos
Average number of
different clones integrated
Average number of
different clones
integrated: LacZ embryos
pool A 9 5 31 3.1 5.0
pool B 10 16 43 3.1 4.0
pool C 10 2 39 0.5 3.0
pool D 10 21 40 4.8 7.0
pool E 10 4 42 0.4 2.0
pool F 20 16 52 2.0 3.8
pool G 20 12 54 0.9 2.3
pool H 20 8 88 2.2 6.1
Total 109 84 389 2.1 4.2
Summary of injected pools.
doi:10.1371/journal.pone.0015741.t002
In Vivo Enhancer Screen
PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15741
tomography (OPT) (Figure 4). Remarkably, we found that 5F7-
LacZ and Olig genes shared a very specific expression domain in
the posterior diencephalon, suggesting that the identified tran-
scriptional enhancer could be directing expression of Olig genes in
this tissue. While the human and chicken elements drive
expression of the reporter in very similar domains, the domain
elicited by the mouse sequence seems more extensive. The
activities of the orthologous elements may be slightly different or
interpreted in a different way by the murine transcriptional
machinery. Moreover, we cannot be certain the enhancers behave
exactly as they would in their normal genomic context. We further
probed the activity of enhancer 5F7 by generating adult mice
transgenic for 5F7-LacZ. Expression of the reporter was
investigated on adult brain sections and was observed in neurons
of layers I, II, and III of the cortex (Figure 5). Thus, 5F7 acts as an
enhancer in neural tissue both during embryonic development and
adulthood.
Clone 5F7 contacts the OLIG2 promoter
If clone 5F7 indeed regulates the OLIG genes, we hypothesized
that they may interact in chromosomes. We tested this hypothesis
using circular chromosome conformation capture (4C) in U87
(human glioblastoma) and K562 (human erythromyeloblastoid
leukemia) cells with clone 5F7 as bait (5F7-DpnII). The library was
generated by digestion with DpnII. We found that the bait
interacted with a fragment just upstream of the OLIG2
transcription start site (Figure 6), consistent with the hypothesis
that the enhancer contributes to the expression pattern of OLIG2.
Figure 2. Conserved and Non-conserved enhancers. Genomic location of the 3 identified enhancers in the UCSC genome browser. Middle:
Close-up on the 3 enhancers, showing that 2 are not significantly evolutionarily conserved. Bottom: expression pattern of characteristic embryos
transgenic for the corresponding clone. Arrowheads highlight expression in the neural tube and trigeminal ganglion.
doi:10.1371/journal.pone.0015741.g002
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In K562 cells, that do not express OLIG2, only 9 tags were
recovered from the single intron of OLIG2, 250 bp downstream of
the described OLIG2 basal promoter [32,33]. In contrast, OLIG2-
expressing U87 cells [34], showed a much stronger interaction
between 5F7 and OLIG2, with 13-fold more tags (118 tags)
recovered (after normalization for the total number of tags). The
fragment recovered from the U87 cells (hg18: chr21: 33317543–
33318140) is slightly more centromeric (2.1 kb and 7 DpnII sites
separate the U87 fragment from the K562 fragment) than the
K562 fragment (hg18: chr21: 33320303–33320554), and overlaps
with the promoter of OLIG2. The two cell lines thus show different
chromatin dynamics that could be reflecting that fact that one
expresses OLIG2 (U87) while the other doesn’t (K562). The
relative proximity between OLIG2 and 5F7 (14.5 kb) raises the
possibility that the observed interactions stem from a proximity
effect rather than from an active process. In order to further
discriminate between these possibilities we performed quantitative
3C using TaqMan assays in biological duplicates (Figure 6). We
designed-dual labeled probes encompassing the potential ligation
products between 5F7 and a series of eleven DpnII fragments
surrounding the CNC (Table S4). Crosslinking efficiency decays
relatively fast from 10 fold (+1.1 kbp) to 1.8 fold (+4.4 kbp) in U87
suggesting that the proximity effect of crosslinking does not extend
far from the bait as observed earlier under the same conditions
[35]. Interestingly, crosslinking efficiency increases again at
+5.8 kbp from 5F7 (12 fold) recapitulating the interaction
observed in 4C. A smaller peak of enrichment (3.5 fold) is present
at +14.5 kbp corresponding to the promoter region of OLIG2,
which was shown to interact with 5F7 in 4C. Another site
(+35.1 kb), between OLIG2 and OLIG1, shows strong association
(8.7 fold) with 5F7 in U87 cells. A significantly weaker interaction,
but still above background, is observed at this site in K562 (3.4
fold). The potential function of this interaction is unclear although
it may suggest that 5F7 is capable to fold over OLIG2. Interestingly
this site lies near a block of evolutionary conservation. A similar
interaction however was not detected in 4C. In addition, we could
not design appropriate TaqMan probes for the 4C DpnII
fragment identified in K562 right upstream of OLIG2
(+16.5 kbp). Overall, these data suggest that the interaction
between 5F7 and OLIG2 in U87 cells is genuine and not an
artifact due to proximity. This observation adds further support to
the conclusion that the identified enhancer could be regulating
OLIG2.
Discussion
We present a rapid and unbiased in vivo method to screen a large
genomic fragment for enhancer activity. The high efficiency of
lentiviral vector-mediated transgenesis [26] enables testing of
many sequences in a single experiment. Moreover, the method
bypasses time-consuming mouse breeding since it does not need
the generation and maintenance of transgenic lines, but is instead
based on the analysis of F0 embryos. The method described here
substantially diminishes the number of oocyte injections and foster
mice and thus increases the throughput compared to single
construct injections [19]. Our demonstration that injecting pools
of up to 20 different lentiviral vectors leads to the successful
identification of transcriptional enhancers allows the scale-up of
this enhancer screen covering up to megabases of DNA.
We have extensively screened a mouse BAC for enhancer
activity, with over 74% of the total sequence tested. To our
knowledge, this is the first broad unbiased (i.e. not driven by
evolutionary conservation) screen for transcriptional enhancers in
transgenic mice. We identify 3 enhancers with a high degree of
confidence, the most robust of which drives expression of the
reporter in the posterior diencephalon and neural tube. Impor-
tantly, of the three identified enhancers, only one is strongly
evolutionarily conserved. The two other regulatory elements show
no detectable sequence conservation whatsoever and would not
have been uncovered in a conservation-based candidate approach.
This observation indicates that exhaustive screens for functional
elements should not be restricted to conserved DNA elements.
Moreover, while current annotation of the mouse genome
(NCBI37-mm9) does not display predicted transcription factor
binding sites, the human orthologous fragment of enhancer 5F7
harbours an abundance of predicted binding sites (FoxC1, Oct-B1,
POU3F2). It is possible that even the non-conserved elements may
contain a short sequence of conservation that is responsible for
enhancing activities, particularly since the typical transcription
factor binding site is just a few nucleotides-long. Interestingly, the
two non-conserved enhancers, separated by only 57 kb, displayed
the same pattern of reporter expression in the trigeminal ganglion.
They could represent « shadow enhancers » with overlapping
activities [36], but it remains unknown whether the target gene of
these enhancers is Olig or a more distant or unannotated gene.
Since we screened a BAC mapped within an orthologous
fragment studied in the ENCODE project pilot phase, we
asked whether our identified conserved enhancer 5F7 carried
Figure 3. Characterization of enhancer 5F7. (A) Genomic location of clone 5F7 (pool A). Bottom: Close view of genomic location of 5F7 with the
UCSC vertebrate conservation track and the VISTA alignment of human and chicken orthologous regions. The yellow box shows the boundaries of
the conserved fragment that we subsequently cloned (5F7 CNC). (B) Embryos injected with clone 5F7 individually express the reporter in the neural
tube and brain (arrowheads). 3rd and 4th images are back and front views of the same embryo. (C) Embryos injected with clone 5F7 CNC individually
also express the reporter in the neural tube and brain. 3rd and 4th images are back and front views of the same embryo. Arrowheads highlight
expression in the neural tube and trigeminal ganglion. (D) Lateral and frontal views of 3 embryos injected with chicken 5F7 orthologous sequence
displaying posterior diencephalon staining (arrowheads). (E) Lateral and frontal views of 3 embryos injected with human 5F7 orthologous sequence
displaying posterior diencephalon staining (arrowheads).
doi:10.1371/journal.pone.0015741.g003
Table 3. Frequencies of phenotypes observed for clone 5F7.
Mouse 5F7 (n=7) Mouse 5F7 CNC (n=24) Human 5F7 (n =16) Chicken 5F7 (n =17)
Neural tube 57% 54% 31% 52%
Posterior Diencephalon 14% 13% 81% 94%
Frequencies of neural tube and posterior diencephalon staining for embryos injected with: Mm5F7, Mm5F7 CNC, Gal5F7, Hs5F7.
doi:10.1371/journal.pone.0015741.t003
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annotations suggestive of function. Human 5F7 does not show any
significant DNaseI hypesensitivity in the seven cell lines tested
(CD4+ T cells, GM06990 lymphoblastoid, HeLa S3 cervical
carcinoma, HepG2 liver carcinoma, H9 human embryonic stem,
IMR90 human fibroblast, K562 myeloid leukemia-derived).
Interestingly, human 5F7 is mostly covered by repressive
chromatin marks (H3K27me3 mainly) in all cell lines investigated
by ENCODE (erythroleukaemia, umbilical vein endothelial,
skeletal muscle myoblast, mammary epithelial, lymphoblastoid,
embryonic stem, epidermal keratinocyte, lung fibroblast). Howev-
er, the most conserved part of human 5F7 is marked by
monomethylation on lysine 4 of histone H3 (H3K4me1) in
embryonic stem cells (H1-hESC), a modification associated with
enhancers [37,38]. This suggests that the locus is tightly regulated
and mostly repressed but can be activated in a specific spatio-
temporal manner. Such a tight control pattern would be
compatible with the likely regulation of OLIG genes. These data
should be treated with caution however as they originate from
non-neural human cell lines that likely differ in their regulation of
this locus compared to LacZ positive cells in our E11 murine
embryos. We also looked at p300 binding sites in forebrain,
midbrain and limbs of E11 mouse embryos (data from [39]), but
none of our identified enhancers overlapped with a peak of p300
binding in these tissues.
The ENCODE project pilot phase had previously described
several functional regions that showed no evidence of evolutionary
constraint [23]. Likewise, another report had subsequently
suggested that non-conserved elements could also harbour
enhancer activities in zebrafish transgenics [20], but a broad
unbiased screen had not so far been conducted in mice. Here, we
provide further evidence that non-conserved sequences with
enhancer activity exist. This observation has important implica-
tions regarding the annotation of genomes and the identification of
disease-related variation. It is noteworthy that our study presented
two limitations precluding the exhaustive identification of
enhancers in the DNA region under study. First, we concentrated
our analysis on a narrow window of embryonic development.
Second, overlapping signals may have masked the activity of some
discrete enhancers.
To increase the likelihood of discovering sequences potentially
associated with human disorders, we set out to study a region
syntenic with human chromosome 21 that harbours the OLIG1 and
OLIG2 genes. These genes are specifically expressed in the CNS,
hence their dysregulation is potentially involved in Down
Syndrome. A recent study in a mouse model of Down Syndrome
confirmed that Olig genes triplication indeed causes neurological
phenotypes [40]. Moreover, OLIG2 deregulation has been associ-
ated with disorders such as schizophrenia [41,42] and Alzheimer’s
disease [43]. Our in situ hybridisation and chromosome conforma-
tion capture data support the hypothesis that enhancer 5F7
contributes to the expression pattern of OLIG genes in the posterior
diencephalon but could also be regulating other more distant genes.
The specificity of this CNS transcriptional enhancer slightly differed
between the human, chicken and mouse orthologous sequences. All
three highlighted the posterior diencephalon and the neural tube.
However, the human and chicken elements displayed very similar
staining with a higher frequency of diencephalon staining and lower
frequency of neural tube staining, relative to the mouse element.
These differences could be explained by an inaccurate ‘‘reading’’ of
foreign DNA fragments by the murine transcriptional machinery.
However, the recent study of a transchromosomal mouse carrying
human chromosome 21 showed that the foreign chromosome could
be recognized and interpreted in the appropriate spatio-temporal
manner by the host machinery. In hepatocytes of this mouse, the
human chromosome was recognised by murine transcription factors
to dictate accurate gene-expression despite the lack of conservation
of certain DNA binding motifs; showing that adequate instructions
to direct species-specific transcription must be embedded in the
genetic sequence [44]. Alternatively, the differences we observe
could be evolutionarily relevant and represent species-specific
differential regulation. A recent example of such differences was
reported for an enhancer gaining a limb expression domain in
human relative to chimpanzee [45]. However, the high relatedness
of the expression patterns induced by all three orthologous 5F7
elements strongly suggests a conserved role for this enhancer in the
three species. Furthermore, the combination of all the patterns seen
with the three enhancers includes all the patterns seen in Olig1 and
Olig2 in situ hybridizations. For example, the less penetrant LacZ
Figure 4. Optical projection tomography of 5F7-LacZ stained embryos. Optical projection tomography (OPT) images of selected LacZ
stained embryos. One representative embryo for each orthologous mouse human and chicken enhancer was selected. Arrowheads highlight
expression in the trigeminal ganglion. Top: sagittal sections. Bottom: frontal sections. (Right) In situ hybridisations for Olig1 and Olig2 genes.
doi:10.1371/journal.pone.0015741.g004
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neural tube and hindbrain domains are visible in the Olig2 in situ
hybridization. How different activities of this enhancer are
generated with respect to Olig1 or Olig2 at the original locus in
different tissues is not known and could be dependant on other
regulatory influences coming from additional cis-acting elements.
It is becoming increasingly apparent that sequence conservation
alone is not a sufficient criterion to predict all regulatory elements
and that other features can facilitate the identification of functional
sequences. For example, a recent study showed that p300
association accurately predicted tissue-specific activity of enhanc-
ers [39], while evolutionary conservation of the three-dimensional
structure of DNA has also been proposed as a marker of functional
elements [46]. It is likely that a combination of chromatin marks
[37,47], bound proteins [39], DNaseI hypersentivity [48], three-
dimensional structure [46] and sequence conservation criteria
along with other yet unknown parameters will be required to
improve the prediction of regulatory elements. The method we
present here could be scaled up to cover large chromosomal
regions, and determine what fraction of the conserved and non-
conserved genome has regulatory potential.
Materials and Methods
Library construction
Murine BAC RP23-356P18 (219.6 kb) was obtained from CHORI
(http://www.chori.org/) and partially digested with CviJ. Fragments of
2–4 kb were purified and cloned in pRRLbLac (Trono lab: http://
tronolab.epfl.ch/). Clones were end sequenced and re-mapped to the
BAC. Gaps were filled-in by cloning PCR fragments. The library
contains 142 clones and covers more than 90% of the BAC (Table S1),
after exclusion of the large gap containing an LTR repeat.
Lentivector-mediated transgenesis
Lentiviral vectors were generated by co-transfecting the transfer
vector with PMD2G and R8.74 plasmids (Trono lab: http://
tronolab.epfl.ch/) in 293T cells. One 50–60% confluent 15 cm
diameter petri dish was used for each fragment. 3 collections of
14 ml of supernatant were performed, at 24 h (transfection medium
changed after 16 h), 36 and 48 h after transfection. 7 ml (pools of
10) or 3.5 ml (pools of 20) of each vector were pooled (70 ml) for
ultracentrifugation in two 35 ml-tubes, the rest of the supernatant
Figure 5. Expression of 5F7-LacZ in adult brain. (A-B-C) Brain sections of adult mice transgenic for 5F7-LacZ at different magnifications.
Expression of the reporter is specific to layers I, II, and III of the cortex. Cell nuclei are visible at higher magnification (C).
doi:10.1371/journal.pone.0015741.g005
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was used to prepare individual vectors. Pools were resuspended in
3620 ml for injection, individual vectors in 3610 ml. For each clone
of the library F0 transgenic embryos were generated by perivitelline
injection of lentivectors in mouse fertilised oocytes as described in
[26]. Briefly, 50–150 oocytes were injected and transferred to foster
mothers (16 embryos/foster). Fosters were sacrificed to recover 5–
14 E11.5 embryos/foster. 31 to 69 embryos were recovered for
pools,,30 or more for individual vectors. Embryos were stained for
LacZ in 0.8 ml assay mix in 24-well plates. Staining pattern were
identified and photographed for analysis.
Genotyping
A PCR assay was developed to genotype each injected clone of the
library individually using one clone specific primer (Table S2) and the
BGdown primer (AGCAATAGATGGCTCTGCCCTGAC) in the
beta globin minimal promoter, which is common to all. Each embryo
was genotyped for all clones of the pool potentially integrated.
Statistical analysis
P values for staining patterns are obtained by Fisher’s exact test
on a 262 table. For a particular construct, frequency of observed
pattern is compared with frequency of observing this pattern in all
other beta galacotosidase embryos having received other random
fragments of the library.
Optical projection tomography
To further characterize LacZ stainings, Optical Projection
Tomography (OPT) (http://www.bioptonics.com/) was used to
generate 3D reconstruction and virtual sections of embryos.
In situ hybridization
RNA Probe Synthesis: Digoxygenin-tagged RNA probes were
generated from the DNA templates T3961 and MH_QR465, for
Olig1 and Olig2 respectively. T3961 was obtained through the
Figure 6. 3C and 4C interactions between 5F7 and Olig2. 3C and 4C interactions between 5F7 and OLIG2 in K562 and U87 cells.
3C: Crosslinking efficiency was measured for each probes relative to a fully digested/ligated BAC (RP11-760B14; chr21: 33199567–33414452) and then
ploted relative to a probe located 102 kb upstream of 5F7 where crosslinking is expected to be at background levels (the2102 kbp site is not shown
here). 4C: A DpnII fragment containing clone 5F7 was used as bait. The vertical lines correspond to the log2 of the number of tags recovered by the
bait in K562 and U87 cells. The peak at the bait represents self-ligation of 5F7.The position of 5F7 is indicated by a light blue strip whereas the U87
4C-specific interactions are indicated by light-red strips.
doi:10.1371/journal.pone.0015741.g006
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Eurexpress Consortium (www.eurexpress.org) and MH_QR465
was a kind gift of Pr. G. Eichele (MPI, Go¨ttingen). In vitro
transcription was carried out in 1 mM rATP, rCTP, rGTP,
0.65 mM rUTP, and 0.35 mM digoxigenin-UTP (Roche labeling
kit), 1 ml of ribonuclease inhibitor (40 U/ml MBI Promega), 0.5 mg
of DNA template, 0.5 ml of RNA polymerase (T7: 50 U/l, SP6:
20 U/l, both New England Biolabs), in 20 ml.
In situ hybridization: E11.5 mouse embryos were embedded in
OCT. Embryos were sagitally sectioned at 25 um thickness on
superfrost slides. Tissue sections were then fixed in 4% paraformalde-
hyde, acetylated and ISHwere performed as described previously [49].
Circular chromosome conformation capture (4C)
Chromosome conformation capture was performed as described
[50] with the following modifications. Cells were grown in 50 ml
RPMI medium (Invitrogen) supplemented with 10% heat inactivated
fetal bovine serum and 100 mg streptomycin/penicillin at a concen-
tration of about 26105 cells/ml (16107 cells). Crosslinking with
formaldehyde (1% v/v) was allowed to proceed for 10minutes at room
temperature directly in the cell media prior to quenching with
125 mMglycine. Cells were washed twice in ice-cold PBS and lysed for
1 hour on ice with mild stirring in 20 ml 1xTBS-Tween (10 mMTris-
HCl pH 7.5, 3 mM CaCl2, 2 mM MgCl2, 15 mM NaCl, 0.5% v/v
Tween 40) supplemented with protease inhibitor (Complete, Roche)
and 5 mM PMSF. The cell lysate was homogenized with 15 strokes in
a Douncer (‘A’ or tight pestle) and washed with PBS (centrifugation:
19200 g at 4uC for 10 minutes). The lysate was subsequently
resuspended in 5 ml 25% (w/v) sucrose-TBS and underlayed with
5 ml 50% (w/v) sucrose-TBS. Nuclei were pelleted for 20 min (4600 g
at 4uC), washed under the same conditions with 5 ml 25% (w/v)
sucrose-TBS and resuspended in 500 ml 1.2 x DpnII restriction buffer.
Restriction with DpnII, ligation, crosslink reversal and DNA
purification were carried out as described earlier [35].
The 4C library was generated from 200 ng of ligated DNA with
two successive rounds of PCR amplification using 2 nested pairs of
primers. The PCR (20pmoles of round A primers) were performed
under the following conditions during RoundA: 98uC for 30 s, 34
cycles of 98uC for 10s/65uC for 30s/72uC for 90 s and followed by
a final elongation step at 72uC for 3 min. A 1/100 dilution of round
A DNA is then amplified with 40pmoles of round B primers (94uC
for 3 min, 32 cycles of 94uC for 30ss/65uC for 30s/72uC for 90 s
and followed by a final elongation step at 72uC for 3 min). The
primers used during the second round of amplification have
additional nucleotides at their 59 end (59-AATGATACGGCGAC-
CACCGA and 59-CAAGCAGAAGACGGCATACGA). These
are required for DNA colony amplification on the cluster station
as part of the Illumina Genome Analyzer high-throughput
sequencing procedure. The library was gel purified to reduce the
amount of DNA originating for self-ligation of the DpnII restricted
bait. Sequencing was carried out at Fasteris life sciences (http://
www.fasteris.com) using an Illunima Genome Analyzer. The
sequencing primers were designed to anneal just upstream of the
DpnII (GATC) restriction site on one side of the bait. Hence all
sequences start with GATC.
Chromosome conformation capture (3C)
For quantitative Taqman PCR, we designed 11 assays comprising
the PCR primers and a dual-labeled probe sitting at the predicted
DpnII junction between the target and bait regions (Table S4). PCR
reactions were set up as described earlier [35]. Technical triplicates
were performed on biological duplicates both in K562 and in U87.
For the 3C samples, 200 ng of DNA was used per well, and for the
BAC RP11-760B14 (chr21: 33199567–33414452), 5 ng of digested
and randomly ligated DNA was used. Normalization for each assay
was performed using the values obtained from BAC experiment.
Enrichment was calculated with respect to the most centromeric
probes (2102 kb), which showed very low levels of interaction.
Supporting Information
Table S1 Coordinates of the 142 clones of the library. All map
to Mmu16 and positions are given for mm8 (Feb. 2006) mouse
genome assembly.
(PDF)
Table S2 All clones injected, and the sequence of the primer
used to genotype. The orientation of each clone is indicated. ‘‘+’’
denotes that the sequence upstream of the lacZ reporter is the
positive strand. ‘‘2’’ indicates the negative strand (Mm8, UCSC
genome browser http://genome.ucsc.edu/).
(PDF)
Table S3 Summary of all injected clones. Coordinates, ID, Pool,
integration status.
(PDF)
Table S4 3C primers and probe.
(PDF)
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